Katharina N. Steinitz

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

florio HAEMO-A Digital Medical Device for Monitoring of Treatment, Symptoms and Physical Activities for People Living With Haemophilia.

florio HAEMO-A Digital Medical Device for Monitoring of Treatment, Symptoms and Physical Activities for People Living With Haemophilia.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: July 31, 2025

Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells.

Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells.

Journal: Frontiers in immunology

Published: June 22, 2022

Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms.

Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms.

Journal: Haematologica

Published: January 30, 2018

Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A.

Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: November 30, 2016

Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A.

Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A.

Journal: Blood

Published: November 03, 2015

The EPIC study: a lesson to learn.

The EPIC study: a lesson to learn.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: February 24, 2015

Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis--new insight provided by pharmacokinetic modelling.

Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis--new insight provided by pharmacokinetic modelling.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 13, 2014

CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.

CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.

Journal: Blood

Published: March 08, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026